Company Filing History:
Years Active: 2003-2010
Title: The Innovative Contributions of Michael R. Lawrence
Introduction
Michael R. Lawrence is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors for various receptors and enzymes. With a total of 3 patents to his name, Lawrence's work has the potential to impact the treatment of several diseases.
Latest Patents
One of his latest patents involves the development of novel pyridyl or phenyl ureas and their analogues. These compounds serve as selective inhibitors of the human P2Y receptor, offering new avenues for pharmaceutical compositions aimed at treating diseases responsive to modulation of P2Y receptor activity. Another significant patent focuses on sulfonamide lactam inhibitors of Factor Xa. These inhibitors are designed to be useful as anticoagulants in the treatment of cardiovascular diseases associated with thromboses.
Career Highlights
Throughout his career, Michael R. Lawrence has worked with prominent organizations such as Bristol-Myers Squibb Company and Université de Montréal. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Stephen P. O'Connor and Yan Shi. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Michael R. Lawrence's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.